Methylphenidate HCl is a generic prescription stimulant and one of the most commonly prescribed treatments for attention deficit hyperactivity disorder (ADHD). Because of its extensive use in adults and children, methylphenidate comes in a wide variety of dosage forms, including immediate-release and extended-release formats, tablets, capsules, liquids, chewable tablets, and skin patches. The dosage will depend on the format prescribed.
Check our best Methylphenidate prices
Aptensio XR, Concerta, Cotempla XR-ODT, Daytrana, Jornay PM, Metadate CD, Methylin, QuilliChew ER, Quillivant XR, Relexxii, Ritalin, Ritalin LA, Ritalin LA, Ritalin
Methylphenidate HCl
Treats ADHD and narcolepsy
Stimulant, central nervous system agent
Tablet, chewable tablet, long-acting tablet, long-acting capsule, long-acting chewable tablet, patch
By mouth
Methylphenidate reduces the symptoms of attention deficit hyperactivity disorder (ADHD) in adults and children 6 years of age and older. Additionally, immediate-release formats and extended-release tablets are FDA-approved to relieve daytime symptoms of narcolepsy in adults and children 6 years of age and older.
Tablet
5 mg
10 mg
20 mg
Chewable tablet
2.5 mg
5 mg
10 mg
Oral solution (liquid)
5 mg/5 mL
10 mg/5 mL
Extended-release tablet
18 mg
27 mg
45 mg
54 mg
63 mg
72 mg
Extended-release long-acting tablet
10 mg
20 mg
30 mg
40 mg
Extended-release capsule
10 mg
20 mg
30 mg
40 mg
50 mg
60 mg
Extended-release chewable tablet
20 mg
30 mg
40 mg
Extended-release orally disintegrating tablet
8.6 mg
17.3 mg
25.9 mg
Extended-release oral suspension (liquid)
5 mg/5 mL
Patch
1.1 mg/hr
1.6 mg/hr
2.2 mg/hr
3.3 mg/hr
For ADHD:
Immediate-release formulations: 10–60 mg/day taken in two or three doses
Extended-release tablets: 18–72 mg taken once daily in the morning
Extended-release long-acting tablets: 20–60 mg taken once daily in the morning
Extended-release capsules: 10–60 mg taken once daily in the morning
Jornay extended-release capsules: 20–100 mg taken once daily in the morning
Extended-release chewable tablets: 10–60 mg taken once daily in the morning
Extended-release ODT: 17.3–51.8 mg taken once daily in the evening
Extended-release suspension: 20–60 mg taken once daily in the morning
Patch: 1.1 mg/hr–3.3 mg/hr patch used once daily for nine hours
For narcolepsy:
Immediate-release formulations: 10–60 mg/day taken in two or three doses
Extended-release tablets: 18–72 mg taken once daily in the morning
The starting and maximum dosage for children younger than 12 may be lower for many of these formulations.
Methylphenidate HCl
500ml of 10mg/5ml bottle
Methylphenidate HCl
500ml of 5mg/5ml bottle
Methylphenidate HCl
10mg tablet
Methylphenidate HCl
20mg tablet
Methylphenidate HCl
5mg tablet
Methylphenidate HCl
10mg tablet chewable
Methylphenidate HCl
2.5mg tablet chewable
Methylphenidate HCl
5mg tablet chewable
Follow the doctor’s instructions.
Please read the Medication Guide that comes with this drug.
Take immediate-release methylphenidate two to three times daily unless instructed otherwise by the prescriber.
Children may be prescribed only two doses daily.
Take doses 30 to 45 minutes before eating a meal.
Store immediate-release methylphenidate products at room temperature, protected from light and moisture.
Tablets
Swallow tablets whole with a drink of water.
Chewable tablets
Completely chew methylphenidate chewable tablets.
Drink at least eight ounces of water or other liquid to prevent choking.
Oral solution
Use a calibrated oral syringe to measure oral solution doses.
Ask the pharmacist for one if a calibrated oral syringe is not provided with the medicine.
Take one dose daily in the morning.
Jornay PM doses are taken in the evening between 6:30 p.m. and 9:30 p.m.
Doses can be taken with or without food.
Take Aptensio XR, Cotempla XR-ODT, and Jornay PM doses the same way each time.
Store extended-release methylphenidate in a closed container at room temperature protected from light and moisture.
Tablets or capsules
Swallow the tablet or capsule whole with water or other liquid. Do not crush or chew the tablet or capsule.
If swallowing a capsule is difficult, it can be opened, sprinkled on applesauce, and taken that way.
Take the mixture within 10 minutes of preparing it.
Do not chew.
Take a drink of water when finished.
Chewable tablets
Completely chew methylphenidate chewable tablets and swallow.
The 10 and 15 mg tablets are scored to be divided into two smaller doses.
Drink at least eight ounces of water or other liquid to prevent choking.
Orally disintegrating tablets
Do not remove orally disintegrating tablets from the blister pack until ready to administer a dose.
Use dry hands to open the blister pack.
Do not push the tablet through the back of the blister pack. Peel it back, instead.
Place the tablet on the tongue.
Allow it to completely dissolve. Do not crush or chew.
Swallow.
Oral suspension
Vigorously shake the oral suspension before measuring a dose.
Use a calibrated oral syringe to measure doses.
If a calibrated oral syringe is not provided with the medicine, ask the pharmacist for one.
Methylphenidate patches are worn for one day (nine hours).
Use only one patch daily.
Do not cut or trim the patch.
Place the patch on the hip area two hours before the effects are needed.
Avoid the waistline.
Do not touch the adhesive side.
Once attached, hold in place for at least 30 seconds to ensure adhesion.
Do not use bandages, tape, or adhesive to secure the patch to the skin.
Always switch hips when applying the next patch.
Remove the patch nine hours after placement.
Peel off slowly.
Dispose of the patch by folding the adhesive side together, flushing it down the toilet, or throwing it away in a lidded container.
Store unused patches in their unopened pouches at room temperature.
Do not freeze or refrigerate the patches.
Taking a missed dose depends on the format.
Immediate-release methylphenidate
Take a missed dose of immediate-release methylphenidate when remembered.
If it’s almost time for the next dose, skip the missed dose.
Always take doses 30 to 45 minutes before a meal, including missed doses.
Avoid taking methylphenidate IR after 6:00 p.m.
Extended-release methylphenidate
Take a missed methylphenidate ER (extended release) dose if it’s still morning.
Avoid taking a missed dose in the afternoon.
If it’s too late in the day, skip the missed dose and take the next dose in the morning.
Take a missed Jornay PM dose if it’s still evening.
Do not take the missed dose in the morning.
If it’s the next day, skip the missed dose and take the next dose in the evening.
Transdermal methylphenidate patches
If a patch is forgotten, apply the patch when remembered.
Remove the patch at its normal removal time.
If a patch falls off, replace it with a new patch in a different spot on the hip and remove it at its normal time.
This medicine is not right for everyone.
Do not use it if you have had an allergic reaction to methylphenidate.
Tell other healthcare professionals providing treatment that you or your child is taking methylphenidate.
This drug may need to be stopped before certain types of surgery.
Keep all appointments with the prescriber.
Refills are not automatic. Each month’s refill needs a separate prescription.
The prescriber will need to check heart health, blood pressure, and other issues regularly.
The prescriber will need to regularly check a child’s height and weight.
Tell the prescriber if you are pregnant, breastfeeding, or if you have:
Heart problems, including heart disease or a heart defect
High blood pressure
Circulation problems in the fingers or toes
Eye problems, including glaucoma, high eye pressure, or narrow angles
A personal or family history of psychiatric problems, including depression, bipolar disorder, or psychosis
Motor tics, Tourette syndrome, or a family history of Tourette syndrome
Anxiety
A history of drug abuse or addiction
Methylphenidate can cause serious side effects, including:
Serious heart or blood vessel problems, including a heart attack or stroke
Circulation problems in the fingers and toes
High blood pressure
Increased eye pressure
Glaucoma
Prolonged and painful erections
Growth suppression in children
Methylphenidate can worsen or bring on mental health problems such as anxiety, tics, mania, or psychosis.
Methylphenidate can cause dizziness or blurry vision. Avoid driving or other risky activities until you know how this drug affects you.
Methylphenidate can be habit-forming and lead to abuse.
Do not use more than prescribed.
Talk to the prescriber if the drug does not seem to be working.
Methylphenidate is a federally controlled substance. Selling or giving this medicine to another person is hazardous and illegal.
Keep this medicine in a locked and secure location out of the reach of children and other people.
For some extended-release formats, the tablet may appear in the stools.
This is normal and not a cause for worry.
Quillichew XR chewable tablets contain aspartame. People with phenylketonuria may have a serious reaction to this product.
When using methylphenidate transdermal patches, do not expose the patch to heat (heating pads, blow dryers, heated water beds).
Heat can speed up the skin’s absorption of the drug, increasing the risk of side effects.
Do not use methylphenidate if you are using or have used an MAO inhibitor (MAOI) within the past 14 days.
Before starting methylphenidate, tell the prescriber about all your current drugs and supplements, particularly:
Other stimulants
Antidepressants
Blood pressure medications
Drugs that narrow blood vessels (vasopressors)
Coumarin blood thinners (e.g., warfarin)
The antipsychotic drug risperidone
Avoid drinking alcohol.
Do not use topical drugs or products on a methylphenidate patch application site.
Tell other healthcare providers about methylphenidate before they prescribe new medications or schedule medical procedures that require inhaled anesthetics.
Serious side effects
Talk to a healthcare provider if you notice any signs or symptoms of a possible serious side effect, particularly:
Chest pain that may spread, trouble breathing, unusual sweating, fainting, and nausea
Elevated blood pressure
Racing heartbeats
New or worse behaviors, seeing, hearing, or feeling things that aren’t there, or other unusual thoughts or behaviors
Extreme energy or restlessness, confusion, agitation, unusual moods or behaviors
New or worsening tics
Seizures
Blurred vision, vision changes, sensitivity to light, eye pain
Cold, numb, discolored, or painful fingers or toes
Unexplained sores or wounds on the fingers or toes
Painful or prolonged reactions
Slowed growth or weight loss in children
Allergic reaction: Itching, hives, skin rash, swelling of the face, mouth, or throat, trouble breathing, trouble swallowing
Less serious side effects
Trouble sleeping
Decreased appetite
Headache
Emotional swings
Abdominal pain
Dry mouth
Nausea
Vomiting
Weight loss
Irritability
Aptensio XR methylphenidate hydrochloride extended-release capsule prescribing information, DailyMed (NIH National Library of Medicine)
Concerta drug summary, Prescriber’s Digital Reference (PDR)
Concerta methylphenidate hydrochloride extended-release tablet prescribing information, DailyMed (NIH National Library of Medicine)
Cotempla XR-ODT methylphenidate orally disintegrating tablet prescribing information, DailyMed (NIH National Library of Medicine)
Daytrana methylphenidate patch prescribing information, DailyMed (NIH National Library of Medicine)
Jornay PM methylphenidate hydrochloride capsule prescribing information, DailyMed (NIH National Library of Medicine)
Methylin methylphenidate hydrochloride solution prescribing information, DailyMed (NIH National Library of Medicine)
Methylphenidate hydrochloride CD extended-release capsule prescribing information, DailyMed (NIH National Library of Medicine)
Methylphenidate hydrochloride chewable tablet prescribing information, DailyMed (NIH National Library of Medicine)
Methylphenidate hydrochloride tablet prescribing information, DailyMed (NIH National Library of Medicine)
Quillichew ER methylphenidate hydrochloride extended-release chewable tablet prescribing information, DailyMed (NIH National Library of Medicine)
Quillivant XR methylphenidate hydrochloride extended-release suspension tablet prescribing information, DailyMed (NIH National Library of Medicine)
Relexxii methylphenidate extended-release tablet prescribing information, DailyMed (NIH National Library of Medicine)
Ritalin LA methylphenidate hydrochloride extended-release capsule prescribing information, DailyMed (NIH National Library of Medicine)
Los ahorros en recetas varían según la receta médica y la farmacia, y pueden alcanzar hasta un 80% de descuento sobre el precio en efectivo. Este es un plan de descuento de recetas médicas. NO es un seguro ni un plan de medicamentos de Medicare. El rango de descuentos para las recetas médicas que se brindan bajo este plan, dependerá de la receta y la farmacia donde se adquiera la receta y puede otorgarse hasta un 80% de descuento sobre el precio en efectivo. Usted es el único responsable de pagar sus recetas en la farmacia autorizada al momento que reciba el servicio, sin embargo, tendrá el derecho a un descuento por parte de la farmacia de acuerdo con el Programa de Tarifas de Descuento que negoció previamente. Towers Administrators LLC (que opera como “SingleCare Administrators”) es la organización autorizada del plan de descuento de recetas médicas ubicada en 4510 Cox Road, Suite 11, Glen Allen, VA 23060. SingleCare Services LLC (“SingleCare”) es la comercializadora del plan de descuento de prescripciones médicas que incluye su sitio web www.singlecare.com. Como información adicional se incluye una lista actualizada de farmacias participantes, así como también asistencia para cualquier problema relacionado con este plan de descuento de prescripciones médicas, comunícate de forma gratuita con el Servicio de Atención al Cliente al 844-234-3057, las 24 horas, los 7 días de la semana (excepto los días festivos). Al utilizar la aplicación o la tarjeta de descuento para recetas médicas de SingleCare acepta todos los Términos y Condiciones, para más información visita: https://www.singlecare.com/es/terminos-y-condiciones. Los nombres, logotipos, marcas y otras marcas comerciales de las farmacias son propiedad exclusiva de sus respectivos dueños.
Los artículos del blog no constituyen asesoramiento médico. Su propósito es brindar información general y no sustituyen el asesoramiento, diagnóstico ni tratamiento médico profesional. Si tiene alguna pregunta sobre una afección médica, consulte siempre a su médico u otro profesional de la salud cualificado. Si cree tener una emergencia médica, llame inmediatamente a su médico o al 911.
© 2025 SingleCare Administrators. Todos los derechos reservados
© 2025 SingleCare Administrators. Todos los derechos reservados